Pharmacologic strategies for augmenting cognitive performance in schizophrenia
- 1 January 1999
- journal article
- review article
- Published by Elsevier in Biological Psychiatry
- Vol. 45 (1) , 1-16
- https://doi.org/10.1016/s0006-3223(98)00287-x
Abstract
No abstract availableKeywords
This publication has 98 references indexed in Scilit:
- Prenatal nicotine effects on memory in rats: pharmacological and behavioral challengesDevelopmental Brain Research, 1996
- d-Cycloserine adjuvant therapy to conventional neuroleptic treatment in schizophrenia: an open-label studyJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1994
- Clonidine infusion increases uptake of 99mTc-Exametazime in anterior cingulate cortex in Korsakoff's psychosisPsychological Medicine, 1994
- Preferential activation of dopamine overflow in prefrontal cortex produced by chronic clozapine treatmentNeuroscience Letters, 1994
- Continuous ICV infusion of scopolamine impairs sustained attention of rhesus monkeysNeurobiology of Aging, 1993
- Circuitry of Primate Prefrontal Cortex and Regulation of Behavior by Representational MemoryPublished by American Geophysical Union (AGU) ,1987
- Homovanillic acid concentrations in brain, CSF and plasma as indicators of central dopamine function in primatesJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1987
- The effects of physostigmine and scopolamine on recognition memory in monkeysBehavioral and Neural Biology, 1986
- Comparative effects of cholinergic drugs and lesions of nucleus basalis or fimbria-fornix on delayed matching in ratsPsychopharmacology, 1985
- Dopaminergic A10 neurones are involved in cognitive functionsNature, 1980